Coya Therapeutics, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
COYA on Nasdaq
Industry
Pharmaceutical Preparations
Location
12645 Memorial Dr., Suite F1 #305, Houston, TX

Insiders trading volume in the past year

Coya Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bertex LLC 10%+ Owner $6.89M Dec 28, 2022
Wilbur L. Ross Jr Director $660K Jan 2, 2024
Arun Swaminathan Chief Executive Officer, Director $73.6K +$73.5K +68043% Nov 13, 2024
Ann Lee Director $63.3K Jan 1, 2024
David Snyder Chief Financial Officer $63.2K +$12.9K +25.7% Nov 14, 2024
Fred Grossman Chief Medical Officer $20K +$20K Nov 11, 2024
Howard Berman Chief Executive Officer, Director Jun 3, 2024
Anabella Villalobos Director Jan 1, 2024
Hideki Garren Director Jan 1, 2024
Adrian Hepner Chief Medical Officer Feb 27, 2023
Dov A. Goldstein Director Jan 1, 2024
Dieter Weinand Director Jan 1, 2024

Recent Insider Transactions by Companies or Individuals for Coya Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.